Relation of Genetic Polymorphisms in the Cytochrome P450 Gene With Clopidogrel Resistance After Drug-Eluting Stent Implantation in Koreans

Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention

Steven R. Steinhubl, Peter B. Berger, J. Tift Mann et al. · JAMA · 2002 · 3.1K citations

Medicine, Cardiology, Pharmacotherapy +14

Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction

Shlomi Matetzky, Victor Guetta, Michael Shechter et al. · Circulation · 2004 · 1.4K citations · Full text

Medicine, Cardiology, Pharmacology +13

Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects

Jean‐Sébastien Hulot · Blood · 2006 · 929 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.

G. Wilkinson, Joyce Blaisdell, Urs Meyer et al. · Molecular Pharmacology · 1994 · 750 citations

Life Sciences, Genetics, Pharmacology +16

Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation

Wei C. Lau, Lucy Waskell, Paul B. Watkins et al. · Circulation · 2003 · 687 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17